期刊文献+

转基因CHO细胞中VMAT_2抗毒性作用的研究 被引量:7

Study on the mithridatism of VMAT_2 in transgeneic CHO cell
下载PDF
导出
摘要 目的 研究转基因中国仓鼠卵 (CHO)细胞中单胺囊泡转运体 (VMAT2 )的抗毒性作用。方法 利用转 PC1 2 细胞基因到 CHO细胞中形成的转基因 CHO细胞 (c DNACHO) ,采用 MTT比色法检测 1-甲基 -4 -苯基吡啶离子 (MPP+ )对 CHO细胞野生株 (wt CHO)和 c DNACHO细胞的毒性作用 ,并观察利血平——VMAT2 的特异性阻滞剂对 MPP+毒性作用的影响。结果 在 MPP+ 0 .5 m mol/ L 以上浓度 c DNACHO细胞对 MPP+ 敏感性比 wt CHO低得多 ;c DNACHO和 wt CHO对鱼藤酮 (rotenon)的敏感性无显著差异 ;加入VMAT2 的特异性阻滞剂利血平后 ,上述保护作用消失 ,c DNACHO对 MPP+ 敏感性与 wt CHO细胞无差异 ,而单独予以 wt CHO细胞利血平则不能改变它对低浓度 MPP+的敏感性。结论 此保护机制是由转基因细胞中 VMAT2 引起的 ,VMAT2 在转基因的非神经细胞系 (CHO细胞系 )中也能将 MPP+转运至囊泡内 ,从而保护细胞 ;同时也提示 PC1 2 Objective To study the mithridatism of VMAT 2 in transgeneic CHO cell.Methods Using technology of transgene from PC 12 to CHO, MTT reduction assay was used to detect the toxic effect on MPP + to wtCHO and cDNACHO,meanwhile the role of reserpine was observed,including the toxic effect to MPP + on specific blocking agent of VMAT 2.Results cDNACHO to the sensitivity of MPP + was much less than that of wtCHO over concentration of 0.5 mmol/L MPP +; cDNACHO had the same sensitive as wtCHO to rotenon;after the reserpine was added,the above role disappeared,but wtCHO reserpine was given alone,it couldn't change its sensitivity to MPP +.Conclusion VMAT 2 has protective effect on cDNACHO by transporting MPP + to vesicles; PC 12 possesses the antitoxic components.
出处 《临床神经病学杂志》 CAS 2002年第2期69-72,共4页 Journal of Clinical Neurology
基金 南京医科大学创新基金资助 (项目号 MC990 1)
  • 相关文献

参考文献11

  • 1[1]Timothy Denton,Bruce DH.A dopaminergic cell line variant resistant to the neurotoxin 1-Methyl-4-phenyl-1,2,3,6-Tetrahydropyridine.J Neurochem,1987,49:622
  • 2[2]Yongjian Liu,Doris Peter,Ali Roghani,et al.A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.Cell,1992,21:539
  • 3[3]Yongjian Liu,Robert HE.The role of vesicular transport proteins in synaptic transmission and neural degeneration.Annu Rev Neurosci,1997,20:125
  • 4[4]Uhl GR.Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in parkinson's disease.Ann Rev Neurology,1998,43:555
  • 5[5]Trimbele WS,Linial M,Scheller RH.Celluar and molecular biology of the presynaptic nerve terminal.Annu Rev Neurosci,1991,14:93
  • 6[6]Hirsch EC.Mechanism and consequences of nerve cell death in Parkinson's disease.J Neural Transm Suppl,1999,56:127
  • 7[7]Masserana JM,Gong L,Kulaga H,et al.Dopamine induced apoptotic cell death of a catecholaminergic cell line derived from the central nervous system.Mol Parmacol,1996,50:1309
  • 8[8]Hurd Y,Pristupa Z,Herman M,et al.The dopamine transporter and dopamine D2 receptor mRNAs are differentially expressed in limbic-and motor-related subpopulation of human mesencephalic neurons.Neuroscience,1994,63:357
  • 9[9]Uhl GR,Walther D,Mash D,et al.Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.Ann Neurol,1994,35:494
  • 10[10]Takahashi N,Uhl GR.Mouse synaptic vesicular monoamine transporter molecular cloning and genomic structure.Mol Rain Res,1997,49:7

同被引文献87

引证文献7

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部